• Publications
    Expected Returns Articles
  • Research
    Companies Funds Top 40 My Studies
  • Stock Screen
    New Stock Screen Manage Screens
  • Dashboards
    My Dashboards New Dashboard
  • Forum
  • Events
  • Search
  • Contact Us
  • Sign In

Jazz Pharmaceuticals (JAZZ)

Company Ticker Sector | Industry Quality PAR
Jazz Pharmaceuticals JAZZ Healthcare | Biotechnology 69 19.6%
Current Price ( 9/28 4:00PM EDT) $131.03
CAPS Rating (Rate this stock on CAPS)
Expected Income Statement
Current Sales 3,762.9
Sales Growth Forecast 8.3%
Net Profit Margin 33.4%
Projected Shares Outstanding 70.00
EPS - Five year Forecast $26.76
Average P/E Ratio 12.0
Projected Average Price $321.13
Price Appreciation (Annualized) 19.6%
Annual Dividend Yield 0.0%
Projected Annual Return 19.6%
Quality
Financial Strength 73 18.3
EPS Stability 73 18.2
Industry Sales Growth Rate 15.0% 6.9
Industry Net Profit Margin 30.0% 13.9
Calculated Quality Rating 57.2
Fool CAPS

Total Players

285 Outperforms
67 Underperforms
 

All-Stars (64)

44 Outperforms (69%)
20 Underperforms
 
Fundamental Data Updated: 09/01/2023
MIPAR 11.7%  
Sweet Spot 16.7% - 21.7%  
Top In Biotechnology
Ticker Quality PAR
JAZZ 69 19.6%
ALKS 55 21.2%
INCY 57 20.0%
PACB 49 21.2%
REGN 87 11.5%
Top In Healthcare
Ticker Quality PAR
GMED 98 19.1%
INMD 96 25.0%
EW 98 17.6%
RMD 99 15.3%
CVS 79 19.3%

© 2006 - 2023 Manifest Investing. All rights reserved.
About | Terms of Service | Disclaimer | Privacy Policy

Legend
Quality Legend:
Blue Excellent with quality greater than 80.
Green Good with quality between 60 and 80.
Neutral Average or below average with quality between 20 and 60.
Red Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green PAR is within the target range of MIPAR +5-10%, currently 5.1%-10.1%
Yellow PAR is above the target range of MIPAR +10%, currently 10.1%
PAR Projected Annual Return
MIPAR The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
* Not covered by Value Line Standard Edition.
b Uses price-to-book value for valuation purposes.
P/CF Uses price-to-cash flow for valuation.